SLC7A5 and autosomal dominant polycystic kidney disease: Treatment with LAT-1 inhibitor reduces mTOR signaling and attenuation of cyst growth indicated that LAT-1 inhibitor is a potential therapeutic agent for ADPKD (Yamamoto et al., 2017).